2.5 g IV q8h
Data is insufficient in the Pediatric population
No adjustment needed
Adjust dose for CrCl
Infectious Diseases consult required for use.
Restricted per UCLA Policy HS 1444. Should be reserved for patients with little or no other treatment alternatives.
Reserved primarily for management of documented infections caused by CRE
In patients with documented CRE infection